Bevacizumab Combined with Platinum–Taxane Chemotherapy as First-Line Treatment for Advanced Ovarian Cancer: Results of the NOGGO Non-Interventional Study (OTILIA) in 824 Patients

SIMPLE SUMMARY: The OTILIA non-interventional study aimed to assess the safety and effectiveness of a standard treatment regimen for advanced ovarian cancer in Germany. All of the women participating in the study received chemotherapy combined with a targeted treatment called bevacizumab. Among the...

Descripción completa

Detalles Bibliográficos
Autores principales: Sehouli, Jalid, Mustea, Alexander, Oskay-Özcelik, Guelten, Keller, Maren, Richter, Rolf, Tomé, Oliver, Woopen, Hannah, Sommer-Joos, Ann-Katrin, Grabowski, Jacek P., Armbrust, Robert, Wimberger, Pauline
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8507543/
https://www.ncbi.nlm.nih.gov/pubmed/34638225
http://dx.doi.org/10.3390/cancers13194739

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8507543/
https://www.ncbi.nlm.nih.gov/pubmed/34638225
http://dx.doi.org/10.3390/cancers13194739

Ejemplares similares